The Guardian13h agoSource

At-home STI test pulled from Australian shelves after failing to detect infections

The News

The only approved at-home test for chlamydia and gonorrhoea in Australia, made by Touch Biotechnology, has been suspended for six months by the Therapeutic Goods Administration. A review found the test unreliable and prone to false negative results, affecting an unspecified number of users. The suspension highlights concerns about the reliability of self-testing kits for sexually transmitted infections.

Listen to audio summary
0:00 / 0:00

Infographic

Story infographic

The Analysis

Intelligence Brief

Analyzed

Quality-gated

Same as the summary above — this brief adds the distinct fields below.

Why it matters

TGA suspended Touch Biotechnology's approval for six months.

Evidence

The TGA suspension is for six months.

Uncertainty

5 claims still need verification.

Watch next

No forecast extracted yet.

Brain noteGreyMatter sync is quality-weighted until the analysis has enough evidence and source reliability for durable Brain/KG learning.

5 unresolved.

Key findings

0 assessed·5 unverifiable
Unconfirmed

Australia’s only approved home test for chlamydia and gonorrhoea has been pulled from shelves after failing to detect infections for an unspecified number of patients.

The Guardian
Politicalscore: 60
  • TGA suspended Touch Biotechnology's approval for six months.
  • Regulatory action based on review finding high risk of false negatives.

Plain English

<p><strong>Exclusive: </strong>TGA finds Touch Biotechnology test for chlamydia and gonorrhoea ‘is not reliable’ and has affected an unspecified number of people</p><ul><li><p>Get our <a href="https://www.theguardian.com/email-newsletters?CMP=cvau_sfl">breaking news email</a>, <a href="https://app.adjust.com/w4u7jx3">free app</a> or <a…

Emotionally neutral rewrite. Same facts, calmer framing.

What's next

This angle has contested claims

Claims

5 claims checked
0 assessed|0 inaccurate|5 unverifiable
Unconfirmed

Australia’s only approved home test for chlamydia and gonorrhoea has been pulled from shelves after failing to detect infections for an unspecified number of patients.

The Guardian
Unconfirmed

Touch Biotechnology has been handed a six-month suspension by the Therapeutic Goods Administration (TGA).

The Guardian
Unconfirmed

A review by the TGA found the device is not reliable and poses a high risk for false negative results for users.

The Guardian
Unconfirmed

The unspecified number of people were affected by the test failing to detect infections.

The Guardian
Unconfirmed

The TGA suspension is for six months.

The Guardian
AI-assisted analysis · How we work